Lung cancer in women

Código QR

Lung cancer in women

Ra&uacute;l Barrera-Rodriguez,1 Jorge Morales-Fuentes2 1Biochemistry and Environmental Medicine Laboratory, National Institute of Respiratory Disease, 2Lung Cancer Medical Service, National Institute of Respiratory Disease, Tlalpan, Mexico City, Distrito Federal, Mexico Both authors contribu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Barrera-Rodriguez R, Morales-Fuentes J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/164d488bab4d4d409a089c2f56ea90ff
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Targeting PD-1/PD-L1 in lung cancer: current perspectives
por: González-Cao M, et al.
Publicado: (2015)

Update on biomarkers for the detection of lung cancer
por: Jantus-Lewintre E, et al.
Publicado: (2012)

Staging lung cancer: role of endobronchial ultrasound
por: Inage T, et al.
Publicado: (2014)

Cancer biomarker HER-2/neu in breast cancer in Indian women
por: Singhai R, et al.
Publicado: (2011)

Non-small cell lung cancer: the era of targeted therapy
por: Antonoff MB, et al.
Publicado: (2012)

Rare deleterious germline variants and risk of lung cancer
por: Yanhong Liu, et al.
Publicado: (2021)

Effectiveness of maintenance treatments for nonsmall cell lung cancer
por: Eadens MJ, et al.
Publicado: (2011)

Microbiome dysbiosis in lung cancer: from composition to therapy
por: Ning-Ning Liu, et al.
Publicado: (2020)

The voice of postsurgical lung cancer patients regarding supportive care needs
por: Hoffman AJ, et al.
Publicado: (2014)

The p53 breast cancer tissue biomarker in Indian women
por: Patil V, et al.
Publicado: (2011)

Afatinib treatment in advanced non-small cell lung cancer
por: Hurwitz JL, et al.
Publicado: (2011)

Tamoxifen for women at high risk of breast cancer
por: Nazarali SA, et al.
Publicado: (2014)

MET targeted therapy for lung cancer: clinical development and future directions
por: Feng Y, et al.
Publicado: (2012)

Clinical application of a lung cancer organoid (tumoroid) culture system
por: Etsuko Yokota, et al.
Publicado: (2021)

Epiregulin as a therapeutic target in non-small-cell lung cancer
por: Sunaga N, et al.
Publicado: (2015)

Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancer
por: Vlachogianni T, et al.
Publicado: (2013)

Emerging treatment options in the management of non-small cell lung cancer
por: Filosso PL, et al.
Publicado: (2011)

Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
por: Suda K, et al.
Publicado: (2013)

Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer
por: Adrián Sánchez-Fdez, et al.
Publicado: (2021)

Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter
por: Goldfinger LE, et al.
Publicado: (2013)

Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer
por: Stasi I, et al.
Publicado: (2014)

Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer
por: Burns MW, et al.
Publicado: (2015)

Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases
por: Sarah B Goldberg, et al.
Publicado: (2021)

Risk of primary lung cancer after adjuvant radiotherapy in breast cancer—a large population-based study
por: Anna-Karin Wennstig, et al.
Publicado: (2021)

Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics
por: Karachaliou N, et al.
Publicado: (2014)

First-line treatment of advanced ALK-positive non-small-cell lung cancer
por: Gandhi S, et al.
Publicado: (2015)

Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer
por: Zienolddiny S, et al.
Publicado: (2011)

New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer
por: Weise AM, et al.
Publicado: (2014)

Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
por: Minami S, et al.
Publicado: (2015)

Estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer of Indian women
por: Patil AV, et al.
Publicado: (2011)

Management of early breast cancer in older women: from screening to treatment
por: Elomrani F, et al.
Publicado: (2015)

Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer
por: Twelves C, et al.
Publicado: (2011)

A functionally significant SNP in TP53 and breast cancer risk in African-American women
por: Maureen E. Murphy, et al.
Publicado: (2017)

Aged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis
por: Ke Wang, et al.
Publicado: (2021)

Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy
por: Hui Li MD, et al.
Publicado: (2021)

Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions
por: Binghao Li, et al.
Publicado: (2021)

Prevalence of driver mutations in non-small-cell lung cancers in the People’s Republic of China
por: Gou LY, Wu YL
Publicado: (2014)

Comparison of Sleeve Lobectomy for Lung Cancer Using Mini-Thoracotomy and an Optimized Robot-Assisted Technique
por: Tao Shaolin, et al.
Publicado: (2021)

Construction, Validation, and Visualization of Two Web-Based Nomograms to Predict Overall and Cancer-Specific Survival in Patients with Gastric Cancer and Lung Metastases
por: Honghong Zheng, et al.
Publicado: (2021)

Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
por: Vogel VG
Publicado: (2011)